1-20 of 103
Min Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1646: Elucidating the molecular mechanism of action of the first in human SMARCA2 selective degrader PRT3789

Free
Min Wang, Miles Cowart, Joy Cote, Justin Kurian, Stephanie Rodgers, Chaoyi Xu, Corey Basch, Philip Pitis, Klare Bersch, Raul Leal, Liang Lu, Michael Hulse, Andrew Moore, Alexander Grego, Joseph Rager, Tom Emm, Koichi Ito, Neha Bhagwat, Andrew Combs, Sandy Geeganage, Peggy Scherle
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 1646.
https://doi.org/10.1158/1538-7445.AM2025-1646
Published: 21 April 2025
View article titled, Abstract 1646: Elucidating the molecular mechanism of action of the first in human SMARCA2 selective degrader PRT3789
Journal Articles

Abstract 1649: Discovery of first-in-class potent and selective oral degraders of KAT6A that demonstrate anti-cancer activity in pre-clinical models

Free
Monisha Sivakumar, Sarah Pawley, Anthony Reichelderfer, Corey Basch, Jimin Park, Jessica Burtell, Chaoyi Xu, Min Wang, Chun Chen, Justin Kurian, Joy Cote, Miles Cowart, Stephanie Rodgers, Amy Crossan, Joseph Rager, Koichi Ito, Sandy Geeganage, SangHyun Lee, Andrew Combs, Peggy Scherle, Andrew Buesking, Jack Carter
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 1649.
https://doi.org/10.1158/1538-7445.AM2025-1649
Published: 21 April 2025
View article titled, Abstract 1649: Discovery of first-in-class potent and selective oral degraders of KAT6A that demonstrate anti-cancer activity in pre-clinical models
Journal Articles

Multiomics Analysis Reveals Molecular Changes during Early Progression of Precancerous Lesions to Lung Adenocarcinoma in Never-Smokers

Open Access
Yun-Ching Chen, Chia-Lang Hsu, Hui-Min Wang, Shang-Gin Wu, Yih-Leong Chang, Jin-Shing Chen, Yu-Ching Wu, Yen-Ting Lin, Ching-Yao Yang, Mong-Wei Lin, Jang-Ming Lee, Shuenn-Wen Kuo, Ke-Cheng Chen, Hsao-Hsun Hsu, Pei-Ming Huang, Yen-Lin Huang, Chong-Jen Yu, Mehdi Pirooznia, Bevan E. Huang, Rob Yang, Jin-Yuan Shih, Pan-Chyr Yang
Journal: Cancer Research
Cancer Res (2025) 85 (3): 602–617.
https://doi.org/10.1158/0008-5472.CAN-24-0821
Published: 01 February 2025
View article titled, Multiomics Analysis Reveals Molecular Changes during Early Progression of Precancerous Lesions to Lung Adenocarcinoma in Never-Smokers
Open the PDF for Multiomics Analysis Reveals Molecular Changes during Early Progression of Precancerous Lesions to Lung Adenocarcinoma in Never-Smokers in another window
Includes: Supplementary data
Journal Articles

Targeting Fatty Acid Metabolism Abrogates the Differentiation Blockade in Preleukemic Cells

Available to Purchase
Xiaoyu Liu, Yu Liu, Qing Rao, Yihan Mei, Haiyan Xing, Runxia Gu, Junli Mou, Manling Chen, Fan Ding, Wanqing Xie, Kejing Tang, Zheng Tian, Min Wang, Shaowei Qiu, Jianxiang Wang
Journal: Cancer Research
Cancer Res (2024) 84 (24): 4233–4245.
https://doi.org/10.1158/0008-5472.CAN-23-3861
Published: 16 December 2024
View article titled, Targeting Fatty Acid Metabolism Abrogates the Differentiation Blockade in Preleukemic Cells
Open the PDF for Targeting Fatty Acid Metabolism Abrogates the Differentiation Blockade in Preleukemic Cells in another window
Includes: Supplementary data
Journal Articles

B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors

Open Access
Licui Jiang, Fengtao You, Hai Wu, Changsong Qi, Shufen Xiang, Ping Zhang, Huimin Meng, Min Wang, Jiequn Huang, Yafen Li, Dan Chen, Gangli An, Nan Yang, Bozhen Zhang, Lin Shen, Lin Yang
Journal: Cancer Research
Cancer Res (2024) 84 (23): 4066–4080.
https://doi.org/10.1158/0008-5472.CAN-24-0195
Published: 02 December 2024
View article titled, B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors
Open the PDF for B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Estrogen Induces LCAT to Maintain Cholesterol Homeostasis and Suppress Hepatocellular Carcinoma Development

Available to Purchase
Wenzhi He, Min Wang, Xuechun Zhang, Yilan Wang, Dongli Zhao, Wenhua Li, Fang Lei, Min Peng, Zhonglin Zhang, Yufeng Yuan, Zan Huang
Journal: Cancer Research
Cancer Res (2024) 84 (15): 2417–2431.
https://doi.org/10.1158/0008-5472.CAN-23-3966
Published: 01 August 2024
View article titled, Estrogen Induces LCAT to Maintain Cholesterol Homeostasis and Suppress Hepatocellular Carcinoma Development
Open the PDF for Estrogen Induces LCAT to Maintain Cholesterol Homeostasis and Suppress Hepatocellular Carcinoma Development in another window
Includes: Supplementary data
Journal Articles

Abstract 1118: Mitigating radiation-induced lymphopenia using interleukin-15: Preclinical rationale for clinical translation

Free
Priti Gupta, Min Wang, Steven Lin
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1118.
https://doi.org/10.1158/1538-7445.AM2024-1118
Published: 22 March 2024
View article titled, Abstract 1118: Mitigating radiation-induced lymphopenia using interleukin-15: Preclinical rationale for clinical translation
Journal Articles

Abstract 6459: Molecular profiling of advanced non-small cell lung cancer in response to first-line immune checkpoint inhibitors and/or chemotherapy using multimodal real-world data

Free
Xiaoyong Fu, Jordan Kardos, Paola Correa, Min Wang, Li, Jackson Egen, Shahed Iqbal
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 6459.
https://doi.org/10.1158/1538-7445.AM2024-6459
Published: 22 March 2024
View article titled, Abstract 6459: Molecular profiling of advanced non-small cell lung cancer in response to first-line immune checkpoint inhibitors and/or chemotherapy using multimodal real-world data
Journal Articles

Abstract 2302: Innovative blood-based cell-free RNA whole transcriptome sequencing for comprehensive RNA profiling in patient plasma samples and its clinical applications

Free
Fang Liu, Yong Huang, Min Wang, Xiangying Sun, Binggang Xiang, Shidong Jia, Pan Du, Shujun Luo
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 2302.
https://doi.org/10.1158/1538-7445.AM2024-2302
Published: 22 March 2024
View article titled, Abstract 2302: Innovative blood-based cell-free RNA whole transcriptome sequencing for comprehensive RNA profiling in patient plasma samples and its clinical applications
Journal Articles

Abstract 2365: Disrupting IL-11/IL-11R signaling by an efficacious anti-IL-11 antibody 9MW3811 enhances T cell tumor infiltration and synergizes with anti-PD-1 therapies in vivo

Free
Shuang Wang, Chang Zhang, Shasha Jiao, Dadi Zeng, Rongjuan Wang, Min Wang, Weining Lu, Bin Zheng, Xun Gui, Jinchao Zhang
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 2365.
https://doi.org/10.1158/1538-7445.AM2024-2365
Published: 22 March 2024
View article titled, Abstract 2365: Disrupting IL-11/IL-11R signaling by an efficacious anti-IL-11 antibody 9MW3811 enhances T cell tumor infiltration and synergizes with anti-PD-1 therapies in vivo
Journal Articles

Abstract 5255: A B7-H3-CAR-modified Vδ1 T cells showed potentanti-solid tumor potential

Free
Licui Jiang, Changsong Qi, Fengtao You, Shufen Xiang, Ping Zhang, Min Wang, Hai Wu, Kunmin Yan, Jiequn Huang, Huimin Meng, Nan Yang, Shirley Zhang, Lin Shen, Lin Yang
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5255.
https://doi.org/10.1158/1538-7445.AM2024-5255
Published: 22 March 2024
View article titled, Abstract 5255: A B7-H3-CAR-modified Vδ1 T cells showed potentanti-solid tumor potential
Journal Articles

Abstract 5254: The “off-the-shelf ”CD19-CAR-Vδ1T cells demonstrated an enhanced therapeutic effect on B-cell malignancy models

Free
Dan Chen, Fengtao You, Cheng Chen, Shufen Xiang, Ping Zhang, Hai Wu, Zhong Zheng, Min Wang, Xingbing Wang, Huimin Meng, Nan Yang, Bozhen Zhang, Lin Yang
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5254.
https://doi.org/10.1158/1538-7445.AM2024-5254
Published: 22 March 2024
View article titled, Abstract 5254: The “off-the-shelf ”CD19-CAR-Vδ1T cells demonstrated an enhanced therapeutic effect on B-cell malignancy models
Journal Articles

Abstract 3194: Discovery of T cell receptor mimic antibody against MAGE-A4 with single B-cell cloning platform

Free
Hao Cheng, You Wu, Tianfeng Shi, Yang Yu, Min Wang, Chenjun Jia, Wenfang Xin, Hu Liu, Teddy Yang, Danmei Yao
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3194.
https://doi.org/10.1158/1538-7445.AM2024-3194
Published: 22 March 2024
View article titled, Abstract 3194: Discovery of T cell receptor mimic antibody against MAGE-A4 with single B-cell cloning platform
Journal Articles

Abstract 4503: Preclinical characterization of PRT7732: A highly potent, selective, and orally bioavailable targeted protein degrader of SMARCA2

Free
Artem Shvartsbart, Koichi Ito, Joseph Rager, Michael Hulse, Anjana Agarwal, Komali Vykuntam, Jessica Burtell, Min Wang, Justin Kurian, Miles Cowart, Joy Cote, Nick Stahl, Monisha Sivakumar, Anthony Reichelderfer, Jack Carter, Alexander Grego, Andrew Moore, Neha Bhagwat, Ross Kuskovsky, Shanthi Ganesan, Stefan Ruepp, Tom Emm, Philip Pitis, Corey Basch, Klare Bersch, Yongchun Pan, Song Mei, Raul Leal, John Rose, Dani Roth, Chaoyi Xu, Ganfeng Cao, Kris Vaddi, Sang Hyun Lee, Sandy Geeganage, Andrew Combs, Peggy Scherle
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4503.
https://doi.org/10.1158/1538-7445.AM2024-4503
Published: 22 March 2024
View article titled, Abstract 4503: Preclinical characterization of PRT7732: A highly potent, selective, and orally bioavailable targeted protein degrader of SMARCA2
Journal Articles

Abstract 5710: The brain penetrant CDK4/6 inhibitor, PRT3645, is highly effective in combination with other targeted therapies in preclinical models of breast cancer, CRC and NSCLC

Free
Yue Zou, Kirsten Gallagher, Srijita Dhar, Andrew Busking, Sarah Pawley, Ryan Holmes, Xiaowei Wu, Min Wang, Joseph Rager, Tom Emm, Stefan Ruepp, Miles Cowart, Andrew Combs, Kris Vaddi, Sandy Geeganage, Peggy Scherle, Sang Hyun Lee
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5710.
https://doi.org/10.1158/1538-7445.AM2024-5710
Published: 22 March 2024
View article titled, Abstract 5710: The brain penetrant CDK4/6 inhibitor, PRT3645, is highly effective in combination with other targeted therapies in preclinical models of breast cancer, CRC and NSCLC
Journal Articles

Abstract 2598: The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, augments DNA damage repair and predicts therapy responses

Free
Zhiping Li, Xuanmao Jiao, Gordon Robertson, Gabriele Di Sante, Anthony W. Ashton, Agnese DiRocco, Min Wang, Jun Zhao, Sankar Addya, Chenguang Wang, Peter A. McCue, Andrew P. South, Carlos Cordon-Cardo, Runzhi Liu, Kishan Patel, Rasha Hamid, Jorim Parmar, James B. DuHadaway, Nikolaus Schultz, Andrew Kossenkov, Lai Yee Phoon, Hao Chen, Li Lan, Yunguang Sun, Kenneth A. Iczkowski, Hallgeir Rui, Richard G. Pestell
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 2598.
https://doi.org/10.1158/1538-7445.AM2023-2598
Published: 04 April 2023
View article titled, Abstract 2598: The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, augments DNA damage repair and predicts therapy responses
Journal Articles

Abstract 6277: Selective and orally bioavailable SMARCA2 targeted degraders induce synthetic lethality in SMARCA4- deficient solid tumor

Free
Koichi Ito, Artem Shvartsbart, Joseph Rager, Anjana Agarwal, Michael Hulse, Komali Vykuntam, Min Wang, Justin Kurian, Miles Cowart, Joy Cote, Monisha Sivakumar, Jack Carter, Jessica Burtell, Alex Grego, Andrew Moore, Neha Bhagwat, Stefan Ruepp, Tom Emme, Liang Lu, Philip Pitis, Corey Basch, Klare Bersch, Song Mei, Raul Leal, John Rose, Danielle Roth, Ganfeng Cao, Kris Vaddi, Sandy Geeganage, Bruce Ruggeri, Andrew Combs, Peggy Scherle
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 6277.
https://doi.org/10.1158/1538-7445.AM2023-6277
Published: 04 April 2023
View article titled, Abstract 6277: Selective and orally bioavailable SMARCA2 targeted degraders induce synthetic lethality in SMARCA4- deficient solid tumor
Journal Articles

Abstract 494: BPI-452080: A potent and selective HIF-2α inhibitor for the treatment of clear cell renal cell carcinoma, von Hippel-Lindau disease, and other solid tumors

Free
Pingping Wang, Rongwen Yang, Yun Sun, Xuepeng Ju, Jiayu Zhao, Yanju Liu, Xiaoyun Liu, Zhengyao Zou, Jialin Ren, Min Wang, Haibo Chen, Xuegang Yi, Jian Zhang, Teng Ma, Gaoliang Cheng, Lijia Liu, Jing Guo, Xiangyong Liu, Hong Lan, Lieming Ding, Jiabing Wang
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 494.
https://doi.org/10.1158/1538-7445.AM2023-494
Published: 04 April 2023
View article titled, Abstract 494: BPI-452080: A potent and selective HIF-2α inhibitor for the treatment of clear cell renal cell carcinoma, von Hippel-Lindau disease, and other solid tumors
Journal Articles

Abstract 245: Development of a novel urine cell-free DNA preservation method for molecular profiling in genitourinary tumors

Free
jie zhang, fang liu, min wang, cuishan deng, wei mo, seng tao, amy wang, shidong jia, zhixin zhao, pan du, binggang xiang, shujun luo
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 245.
https://doi.org/10.1158/1538-7445.AM2023-245
Published: 04 April 2023
View article titled, Abstract 245: Development of a novel urine cell-free DNA preservation method for molecular profiling in genitourinary tumors
Journal Articles

Abstract 5973: The brain penetrant CDK4/6 Inhibitor, PRT3645, is highly effective in combination with other targeted therapies in preclinical models of NSCLC, CRC, and HER2-positive breast cancer

Free
Yue Zou, Srijita Dhar, Kirsten Gallagher, Andrew Buesking, Sarah Pawley, Ryan Holmes, Xiaowei Wu, Katarina Rohlfing, Min Wang, Joseph Rager, Tom Emm, Stefan Ruepp, Miles Cowart, Jing Ni, Jean Zhao, Bruce Ruggeri, Andrew Combs, Kris Vaddi, Sandy Geeganage, Ashish Juvekar, Sang Hyun Lee, Peggy Scherle
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5973.
https://doi.org/10.1158/1538-7445.AM2023-5973
Published: 04 April 2023
View article titled, Abstract 5973: The brain penetrant CDK4/6 Inhibitor, PRT3645, is highly effective in combination with other targeted therapies in preclinical models of NSCLC, CRC, and HER2-positive breast cancer